have a new treatment option that combines olopatadine hydrochloride and mometasone furoate in the form of a nasal spray. Ryaltris (Hikma Pharmaceuticals PLC and Glenmark Pharmaceuticals Ltd ...

The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults. The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome ...

Joyce Lee for The New York Times Supported by By Caroline ... The resulting repeated need for nasal spray isn’t technically considered an addiction, said Dr. Jonathan Bernstein, an allergist ...

The FDA has approved a nasal spray, called neffy ... Overall, patients and allergy experts alike seem optimistic about a new, small device that can be carried easily and has a good shelf life.

According to the FDA’s announcement, Neffy is meant to be used as “a single dose nasal spray administered into one nostril.” Similar to injection products, “a second dose (using a new ...

The Food and Drug Administration approved a new nasal spray Friday as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray, which is made by ARS ...